Drug discovery cycles are long, regulatory demands aren’t easing, and legacy systems in pharma have compliance issues just by existing. Life science and biotech companies face a specific IT problem: fragmented data, GxP environments that can’t simply be lifted to the cloud, and a vendor market full of generalists with a life sciences slide in their deck. Here’s who’s actually doing this work in 2026 and what to check before picking a partner.
Quick Overview
| Company | HQ | Core Strength |
| DXC Technology | USA | Digital transformation, AI, regulatory systems |
| Atos Eviden | France | HPC for genomics, cybersecurity |
| Persistent Systems | India/USA | Veeva/Salesforce integrations |
| Zühlke Group | Switzerland | Regulated MedTech engineering |
| BearingPoint | Germany | Regulatory consulting, IDMP |
| Wipro HealthTech | India | Pharma manufacturing IT |
| Orion Health | New Zealand | Healthcare data interoperability |
| TCS Life Sciences | India | Global clinical data infrastructure |
| Cerner Enviza | USA | Real-world evidence analytics |
| Leidos Biomedical | USA | Research IT, NIH/NCI programs |
Companies Worth Knowing in 2026
DXC Technology
DXC covers the full drug development lifecycle – R&D data, clinical operations, regulatory submissions, commercial platforms, and post-market surveillance. Their approach combines AI analytics with cloud modernization in GxP-compliant architecture, including validation documentation and audit trail configuration that most cloud integrators skip. Focus areas include RIM workflows, LIMS modernization, pharma supply chain, and medical affairs platforms.
Atos Eviden
Eviden runs HPC infrastructure for genomics – BullSequana systems supporting sequencing pipelines built on GATK and Nextflow. When serious genomic compute is the bottleneck, the infrastructure layer matters as much as the software. Strong cybersecurity practice alongside.
Persistent Systems
Pune-based with a solid US footprint. Persistent connects Veeva, Salesforce, and MuleSoft in pharma commercial and clinical environments – plus they’ve built AI agents that reduce manual pharmacovigilance signal screening.
Zühlke Group
Swiss product engineering firm for regulated MedTech: IEC 62304, IEC 62366, notified body-ready. They’ve shipped products under these standards – not just advised on them. Relevant when a companion diagnostic or connected device is the actual deliverable.
BearingPoint
European consultancy with a track record in regulatory data transformation. Specifically known for IDMP implementation, which many mid-size pharma companies are still working through. Narrow specialty; genuine experience.
Wipro HealthTech
Wipro’s life sciences unit handles pharma manufacturing IT – MES systems, serialization for track-and-trace, batch records. Strong Oracle and SAP coverage. Reliable execution in production environments.
Orion Health
Their Rhapsody integration engine runs in 30+ countries, connecting EMR systems via HL7 FHIR. For biotech running decentralized trials or real-world evidence programs, clean extraction from fragmented source systems is the actual challenge – that’s Orion’s core capability.
TCS Life Sciences
Scale for global programs. Large Veeva and Medidata rollouts for clients including AstraZeneca. For Phase III infrastructure across multiple regions, that operational depth reduces complexity.
Cerner Enviza
Oracle Cerner’s real-world evidence arm – claims data, EHR records, patient registries translated into HEOR and comparative effectiveness evidence. Relevant for biotech building label expansion cases or payer submissions.
Leidos Biomedical Research
Manages the Frederick National Laboratory for Cancer Research. Clinical informatics, biospecimen management, federated data platforms for NIH-funded programs. Not a commercial vendor in the traditional sense, but central to the US public biotech research infrastructure.
How to Choose the Right IT Partner for Life Sciences
Not every vendor that says “pharma” actually means it. A few things worth verifying:
- Regulatory depth – 21 CFR Part 11, Annex 11, IDMP. Non-negotiable starting points.
- Validation experience – CSV and CSA (Computer Software Assurance) aren’t optional.
- Platform know-how – Veeva, Medidata, SAP, Salesforce Health Cloud. Can they connect them or just name-drop them?
- Security – SOC 2, HIPAA compliance at minimum.
- References in regulated environments – First FDA/EMA project is a learning exercise at your cost.
A dedicated life sciences practice is a baseline. Depth is what differentiates.
FAQ
What separates a life sciences IT vendor from a healthcare IT vendor? Healthcare IT covers hospital ops and EHR. Life sciences IT is about drug development, trials, submissions, and manufacturing – different platforms (Veeva vs Epic), different standards (GxP vs HIPAA).
Do small biotech startups need specialized IT partners? Yes. An incorrectly configured LIMS or eTMF creates problems expensive to fix before an FDA inspection. Starting right costs less.
Where does AI fit in life sciences IT right now? Pharmacovigilance automation, literature screening, clinical data cleaning, trial recruitment prediction. Real applications exist; regulatory acceptance is still catching up.
Is cloud safe in a GxP environment? Yes, when set up correctly. AWS, Azure, and Google Cloud have GxP qualification programs. The challenge is validation configuration – not the cloud platform.
